Jeffrey H. Hager
- Cancer Research top 2%
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 4
-
- Prostate Cancer Treatment and Research 3
- Molecular Biology top 10%
- DNA Repair Mechanisms 4
- Histone Deacetylase Inhibitors Research 4
- Mitochondrial Function and Pathology 2
- Genetics top 5%
- Estrogen and related hormone effects 4
-
- Pancreatic function and diabetes 6
-
- Computational Drug Discovery Methods 3
- Co-authors
- Douglas HanahanHans‐Peter GerberMasahiro InoueNapoleone FerraraEdna Chow ManevalIsan ChenEnrico GiraudoJohanna A. Joyce
- Partner nations
- United StatesSwedenUnited Kingdom
In The Last Decade
Jeffrey H. Hager
28 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 705
- Oncology 647
- Pulmonary and Respiratory Medicine 631
- Molecular Biology 1.2k
- Genetics 476
Countries citing papers authored by Jeffrey H. Hager
This map shows the geographic impact of Jeffrey H. Hager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey H. Hager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey H. Hager more than expected).
Fields of papers citing papers by Jeffrey H. Hager
This network shows the impact of papers produced by Jeffrey H. Hager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey H. Hager. The network helps show where Jeffrey H. Hager may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeffrey H. Hager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2019 | 79 | |
| 3 | 2019 | 1 | |
| 4 | 2019 | 0 | |
| 5 | 2019 | 3 | |
| 6 | 2018 | 7 | |
| 7 | 2015 | 36 | |
| 8 | A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509breakdown → | 2013 | 455 |
| 9 | 2013 | 204 | |
| 10 | 2010 | 18 | |
| 11 | 2009 | 16 | |
| 12 | 2008 | 21 | |
| 13 | 2008 | 7 | |
| 14 | 2005 | 25 | |
| 15 | 2004 | 22 | |
| 16 | Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesisbreakdown → | 2004 | 504 |
| 17 | 2002 | 306 | |
| 18 | 2001 | 237 | |
| 19 | 2001 | 5 | |
| 20 | 1999 | 33 |
About Jeffrey H. Hager
Jeffrey H. Hager is a scholar working on Aging, Biological Psychiatry and Oncology, having authored 29 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (6 papers), DNA Repair Mechanisms (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Estrogen and related hormone effects (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Computational Drug Discovery Methods (3 papers), Prostate Cancer Treatment and Research (3 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Cancer Research (705 citations), Oncology (647 citations) and Pulmonary and Respiratory Medicine (631 citations). Jeffrey H. Hager has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Douglas Hanahan, Hans‐Peter Gerber, Masahiro Inoue, Napoleone Ferrara, Edna Chow Maneval, Isan Chen, Enrico Giraudo, Johanna A. Joyce, Doron C. Greenbaum and Matthew Bogyo. Their work appears in journals such as Science, Nature Genetics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.